Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Stage Small Cell Lung Cancer × lutetium Lu 177 dotatate × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Glioblastoma 1 Extensive Stage Small Cell Lung Cancer 1 Advanced Lung Neuroendocrine Tumor 1 Adenoma, Islet Cell 1

Interventions

lutetium Lu 177 dotatate 1 atezolizumab 1 Etoposide 1 Carboplatin 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05142696 2026-03-17

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Novartis

Phase 1/2 Active not recruiting

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡